In a mouse model of N‐nitrosodiethylamine‐induced HCC, telmisartan can activate PPARγ and regulate the NF‐κB‐TAK1‐ERK1/2 axis, inhibiting tumour proliferation and metastasis.107. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.